John Cavan's Insider Trades & SAST Disclosures
John Cavan's most recent trade in Hepion Pharmaceuticals Inc was a trade of 1,200,000 Stock Options done . Disclosure was reported to the exchange on May 18, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John Cavan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hepion Pharmaceuticals Inc | John Cavan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,200,000 | 1,581,060 | - | - | Stock Options | |
| Hepion Pharmaceuticals Inc | John Cavan | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 18 Feb 2021 | 10,000 | 14,800 (0%) | 0% | 2 | 20,000 | Common Stock |
| Hepion Pharmaceuticals Inc | John Cavan | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 25 Nov 2020 | 4,500 | 4,800 (0%) | 0% | 1.6 | 7,290 | Common Stock |
| Hepion Pharmaceuticals Inc | John Cavan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2020 | 160,000 | 381,060 | - | - | Stock Options | |
| Hepion Pharmaceuticals Inc | John Cavan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 215,000 | 221,059 | - | - | Stock Options |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges